The Journal of Allergy and Clinical Immunology
Volume 123, Issue 1 , Pages 224-230.e4, January 2009

Toll-like receptor 7–induced naive human B-cell differentiation and immunoglobulin production

  • Mark C. Glaum, MD, PhD

      Affiliations

    • Division of Allergy and Clinical Immunology, University of South Florida College of Medicine, Tampa, Fla
  • ,
  • Shilpi Narula, MD

      Affiliations

    • Allergy and Immunology Section, University of Pennsylvania School of Medicine, Philadelphia, Pa
  • ,
  • Decheng Song, MD

      Affiliations

    • Allergy and Immunology Section, University of Pennsylvania School of Medicine, Philadelphia, Pa
  • ,
  • Yi Zheng, MD

      Affiliations

    • Allergy and Immunology Section, University of Pennsylvania School of Medicine, Philadelphia, Pa
  • ,
  • Amy L. Anderson, BS, MS

      Affiliations

    • Allergy and Immunology Section, University of Pennsylvania School of Medicine, Philadelphia, Pa
  • ,
  • C. Hank Pletcher, BA, MCI

      Affiliations

    • Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pa
  • ,
  • Arnold I. Levinson, MD

      Affiliations

    • Allergy and Immunology Section, University of Pennsylvania School of Medicine, Philadelphia, Pa
    • Corresponding Author InformationReprint requests: Arnold I. Levinson, MD, University of Pennsylvania School of Medicine, 421 Curie Blvd, 1014 BRB II/III, Philadelphia, PA 19104-6160.

Received 24 December 2007; received in revised form 7 September 2008; accepted 8 September 2008. published online 11 November 2008.

Background

Toll-like receptors contribute to the establishment of adaptive immune responses.

Objective

The reported studies were conducted to examine the effects of the Toll-like receptor (TLR)–7 ligand, resiquimod, on human naive B-cell differentiation.

Methods

Naive human B cells were cultured with resiquimod in the presence or absence of IL-2 and IL-10. Secreted IgM and IgG were measured by ELISA, and IL-6, IL-10, and IFN-α were measured by a multiplex protein array. Cell proliferation was assessed by measuring [3H]thymidine uptake. mRNA for activation-induced cytidine deaminase and Iγ1-Cμ circle transcripts was measured by means of RT-PCR.

Results

Resiquimod induced the production of IgM and, to a lesser extent, IgG by naive human B cells in association with the secretion of IL-6 and IL-10, and a weak proliferative response. IL-2 and IL-10 synergized with resiquimod in markedly augmenting resiquimod-induced IgM and IgG production and proliferation. Resiquimod also stimulated production of IgG by B cells isolated from the blood of a patient with the X-linked hyper-IgM syndrome, with a greater response when these cells were costimulated with IL-2 and IL-10. The stimulated naive B cells from healthy volunteers displayed molecular evidence of immunoglobulin class-switch recombination—namely the appearance of activation-induced cytidine deaminase and Iγ1-Cμ circle transcripts.

Conclusion

Perturbation of TLR-7 on naive human B cells can lead to the induction of immunoglobulin class switch and IgG production in the absence of B-cell receptor cross-linking and CD40-CD40L interaction. The results are relevant to vaccine development and mechanisms by which microbial infection may lead to autoimmunity.

Key words: TLR-7, resiquimod, naive human B cells, immunoglobulin class-switch recombination, X-linked hyper-IgM syndrome

Abbreviations used: AID, Activation-induced cytidine deaminase, APC, Allophycocyanin, BAFF, B cell–activating factor of TNF family, BCR, B-cell receptor, CSR, Class-switch recombination, FITC, Fluorescein isothiocyanate, pDC, Plasmacytic dendritic cell, SIgG, Surface IgG, TLR, Toll-like receptor

 

 Supported by the Immunology Research Fund, University of Pennsylvania School of Medicine.

 Disclosure of potential conflict of interest: A. I. Levinson has consulting arrangements with Talecris and Baxter, has received research support from Novartis and the National Institutes of Health, and has served as an expert witness in vaccine injury litigation. C. H. Pletcher has served as a member of the International Society for the Advancement of Cytometry and the Great Lakes Imaging and Flow Cytometry Association. The rest of the authors have declared that they have no conflict of interest.

PII: S0091-6749(08)01681-3

doi:10.1016/j.jaci.2008.09.018

The Journal of Allergy and Clinical Immunology
Volume 123, Issue 1 , Pages 224-230.e4, January 2009